Carnegie Mellon University

Sanjeev Shroff

Dr. Sanjeev G. Shroff

Distinguished Professor and Gerald E. McGinnis Chair in Bioengineering
Professor of Medicine, University of Pittsburgh

Bio

Dr. Sanjeev Shroff is the Distinguished Professor and Gerald E. McGinnis Chair in Bioengineering and Professor of Medicine at the University of Pittsburgh. Prior to joining the University of Pittsburgh in April 2000, Dr. Shroff was a faculty member at the University of Chicago for 17 years in the Department of Medicine (Cardiology Section). Trained as an electrical engineer (B.Tech., Indian Institute of Technology, Kanpur, India and M.Eng., McMaster University, Canada), Dr. Shroff obtained his doctoral degree in Bioengineering from the University of Pennsylvania.

Dr. Shroff’s research is in the cardiovascular arena, with two main focus areas: (1) Contractile and regulatory proteins and post-translational regulation of cardiac contraction. (2) Role of vascular stiffness in cardiovascular function and potential therapeutic applications of vascular stiffness-modifying drugs and/or hormones (e.g., relaxin). His research efforts have been supported by numerous grants from NIH (continuous funding since 1986), AHA, NSF, and industry sources. He was the recipient of the Established Investigator Award from the AHA (1986-1991) and was elected as a Fellow of the American Physiological Society (1988), Fellow of the American Institute for Medical and Biological Engineering (1999), Fellow of Biomedical Engineering Society (2007), and Fellow of International Academy of Medical and Biological Engineering (2020). Recognized by his colleagues and peers as a consummate teacher and mentor, Dr. Shroff received the Carnegie Science Center Award for Excellence (University Educator) in 2007, the Swanson School of Engineering’s Outstanding Educator Award in 2010, and University of Pittsburgh Chancellor’s Distinguished Teaching Award in 2011. Dr. Shroff has been serving as the Principal Investigator on a NIH-NHLBI pre-doctoral T32 training grant (Cardiovascular Bioengineering Training Program) since 2005 and the Coulter Translational Research Partnership II Program since 2013.